Skip to main content

Margaret Shipp, MD

Boston, MA
United States

Dana-Farber Cancer Institute

Margaret Shipp, MD, is Chief of the Division of Hematologic Neoplasia at Dana-Farber Cancer Institute, Director of the Lymphoma Research Center at Dana-Farber, and a Professor of Medicine at Harvard Medical School. Her research focuses on the clinical and molecular heterogeneity of the large B-cell lymphomas (LBCLs) and Hodgkin lymphomas. Dr. Shipp has led efforts to define molecular signatures of LBCLs and Hodgkin lymphomas, identify biologically distinct subsets of these diseases, and characterize associated rational treatment targets including modulators of the host anti-tumor immune response.

Program Name(s)
Translational Research Program
Margaret Shipp